Penn Capital Management Company, LLC Acadia Pharmaceuticals Inc Transaction History

Penn Capital Management Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $27,040 - $46,907	1,520 Added 0.61%	248,844 $4.6 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $871,908 - $1.33 Million	-41,959 Reduced 14.5%	247,324 $7.74 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $2.13 Million - $3.42 Million	102,280 Added 54.69%	289,283 $6.03 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $3.33 Million - $4.8 Million	187,003 New	187,003 $4.48 Million

288

161M

723K

257K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.39B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Penn Capital Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Penn Capital Management Company, LLC with notifications on news.